The antibody-based pharmaceuticals resource library’s Podcast

Breaking Immune Tolerance to Tumors

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Autoimmunity and T cell activation

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

How To Make Transiently Redirected T Cells

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Chance and Challenge in Tumor Immunotherapy

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

What Are the Related Technologies of T Cell Gene Transfer

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

T Cell-Based Immunotherapy for Tumor

Creative Biolabs files technical advances and professional academic reports on mRNA therapy and puts them in a podcast column. 

Webinar: A Potent SARS-CoV-2 Neutralizing Single-domain Antibody (SdAb) Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19

Creative Biolabs has invited Dr. James Naismith to walk us through the development process of his novel SARS-CoV-2 neutralising sdAbs and how his team has found a candidate demonstrating promising therapeutic efficacy in a hamster model of COVID-19.

Oligonucleotide-based Therapeutics

Oligonucleotides are nucleic acid polymers with potential to treat or manage a wide range of diseases. Oligonucleotide-based therapeutics employ chemically synthesized oligonucleotides with single-stranded DNA or RNA backbone of specific potential. Here, we will discuss the different types of oligonucleotide-based therapies, and some featured solutions provided by Creative Biolabs.

Webinar-Development of Gene Therapy for Genetic Hearing Loss

Creative Biolabs has invited Dr. Jeffrey R. Holt to walk us through how gene therapy has become a promising treatment for genetic hearing loss and how his team developed unique gene therapy strategies for genetic hearing loss.

Webinar-Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington’s Disease Therapies

Creative Biolabs has invited Dr. Markita Landry to walk us through how her team developed a near Infrared Catecholamine nanosensor (nIRCat) and used real-time imaging to find out what drives late-disease decreases in evoked dopamine release, and how to use these findings as optimal therapeutic intervention timepoints for siRNA-based Huntington's disease therapies.